2019
DOI: 10.1016/j.ijpharm.2019.118705
|View full text |Cite
|
Sign up to set email alerts
|

Development, characterization and pharmacokinetics of mupirocin-loaded nanostructured lipid carriers (NLCs) for intravascular administration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(14 citation statements)
references
References 39 publications
0
14
0
Order By: Relevance
“…High cost and time taken for new drug discovery also make the area of AMA research more uninteresting. 2 One of the alternatives is the reformulation of AMA to attain flexibility in application. In 1971, a researcher had isolated a novel antibacterial agent mupirocin (MP) ( 9 (Fig.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…High cost and time taken for new drug discovery also make the area of AMA research more uninteresting. 2 One of the alternatives is the reformulation of AMA to attain flexibility in application. In 1971, a researcher had isolated a novel antibacterial agent mupirocin (MP) ( 9 (Fig.…”
Section: Introductionmentioning
confidence: 99%
“…5 The drug was also found to have an elimination half-life of 20 to 40 min. 2 The noninvasive transdermal route may be an alternative for delivering MP for improved therapeutic efficacy. The route also provides ease of self-administration and removal of therapy at any time course of treatment.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…We incorporated deoxycholic acid into the nanoformulations to obtain a negative charge of -39 mV. This value was advantageous in showing sufficient storage stability because a zeta potential of > 30 or <-30 mV indicates good electrostatic stabilization [37]. The high rate of rolipram encapsulation in the NLCs was attributed to the high lipophilicity of this compound, which allowed it to be retained in the lipid cores of the NLCs.…”
Section: Discussionmentioning
confidence: 99%
“…Liposomes are promising carrier systems for the targeted administration of substances in biomedical applications. They are used to deliver drugs such as small interfering ribonucleic acids, to prevent NPs degradation and to target specific cell types [13][14][15]. Additionally, the directed combination of organic and inorganic particulate systems has several advantages.…”
Section: Introductionmentioning
confidence: 99%